Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Ribi

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Lung Cancer (Amsterdam, Netherlands)|September 27, 2012
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05)Francesco Zappa, Cornelia Droege, Daniel Betticher, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2020
Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12)Hansjörg Vees, Francesca Caparrotti, Eric Innocents Eboulet, et al.
Cancer Nursing|July 9, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Nursing Research|August 6, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Oncology Nursing Forum|August 24, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Seminars in Oncology Nursing|August 13, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies from the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|August 2, 2025
Advancing global cancer symptom science: Insights and strategies from the inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Breast (Edinburgh, Scotland)|March 25, 2014
Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)Arnoud J Templeton, Karin Ribi, Christian Surber, et al.
Journal of Geriatric Oncology|September 20, 2022
Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]Ursula Hasler-Strub, Andreas Mueller, Qiyu Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2018
Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II TrialSilvia Dellapasqua, Kathryn P Gray, Elisabetta Munzone, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|September 27, 2012
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05)Francesco Zappa, Cornelia Droege, Daniel Betticher, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2020
Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12)Hansjörg Vees, Francesca Caparrotti, Eric Innocents Eboulet, et al.
Cancer Nursing|July 9, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Nursing Research|August 6, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Oncology Nursing Forum|August 24, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Seminars in Oncology Nursing|August 13, 2025
Advancing Global Cancer Symptom Science: Insights and Strategies from the Inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|August 2, 2025
Advancing global cancer symptom science: Insights and strategies from the inaugural Cancer Symptom Science Expert MeetingSara Colomer-Lahiguera, Rachel A Pozzar, Carolyn S Harris, et al.
Breast (Edinburgh, Scotland)|March 25, 2014
Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08)Arnoud J Templeton, Karin Ribi, Christian Surber, et al.
Journal of Geriatric Oncology|September 20, 2022
Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]Ursula Hasler-Strub, Andreas Mueller, Qiyu Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2018
Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II TrialSilvia Dellapasqua, Kathryn P Gray, Elisabetta Munzone, et al.
Pageof 9